Physitrack PLC — Transactions under Share Buy-back Programme
Physitrack PLC (Nasdaq First North Growth Market Stockholm: PTRK) (the “Company”) announces that, in accordance with the share buy-back programme announced on 21 July 2026, it has undertaken the following transactions under the programme during the period 17–21 August 2026 (the “week”). The buy-back is carried out by Pareto Securities AB on behalf of the Company.
Summary of transactions
| Period | 17–21 August 2026 |
| Total shares repurchased during the week | 7,250 |
| Volume-weighted average price paid (SEK) | 8.4483 |
| Total consideration paid (SEK) | SEK 61,250 |
| Total shares held by the Company (treasury) following these transactions | 14,500 |
| Total outstanding shares in the Company | 16,260,766 |
| Treasury holding as % of issued share capital* | 0.089% |
*Treasury holding as a percentage of issued share capital is calculated on the basis: shares held by the Company ÷ (total outstanding shares + shares held by the Company), using the most recent figures reported by Pareto Securities. Figures are rounded to the nearest SEK 0.01 / whole share where applicable.
Individual transactions
| Date | Quantity | Average price (SEK) |
| 2026-08-17 | 1,500 | 8.6667 |
| 2026-08-18 | 1,500 | 8.5933 |
| 2026-08-19 | 1,750 | 8.3257 |
| 2026-08-20 | 1,000 | 8.30 |
| 2026-08-21 | 1,500 | 8.3267 |
The buy-back programme is conducted within the safe harbour provided by Article 5 of the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. The programme is executed by Pareto Securities AB on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| 1. Issuer | Physitrack PLC, LEI 213800PC4QYNWHPCP774 |
| 2. Instrument / ISIN | Ordinary shares / GB00BYX22590 |
| 3. Trading venue | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency | SEK |
| 5. Purpose of buy-back | To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR) |
| 6. Executing broker | Pareto Securities AB (non-discretionary mandate) |
This information is disclosed by Physitrack PLC pursuant to Article 5 of the Market Abuse Regulation (EU) No 596/2014, as implemented by Commission Delegated Regulation (EU) 2016/1052.
About Physitrack
Physitrack plc (Nasdaq First North: PTRK), d/b/a Physitrack Group, is a global digital health and wellness SaaS delivering personalized, scalable remote care through its Physitrack and Champion Health platforms.
Physitrack enables healthcare providers to deliver and manage app-guided physical and occupational rehabilitation with measurable patient outcomes and built-in billing and reimbursement support, while Champion Health provides businesses with mental, physical, and financial wellbeing solutions to support workforce health and productivity.
Physitrack Group’s solutions seamlessly integrate with existing systems, including EMR/EHR/PMS connectivity, and are trusted by more than 80,000 providers and organizations across 180+ countries. For more information, visit www.physitrackgroup.com and follow us on LinkedIn and X.
Enquiries regarding this announcement should be addressed to:
Corporate Contact:
Henrik Molin, CEO and co-founder, Physitrack
ir@physitrack.com
media@physitrack.com
Investor and Media Contact:
Investor Relations
Jonathan@harbor-access.com
Tel +1 475 477 9401